CBD is growing in popularity as a medicinal treatment for inflammation, pain
and anxiety. Since the passage of Agricultural Improvement Act of 2018, which
legalized cannabis and hemp products under the FDA’s authority, the cannabis
market has dramatically expanded. Prescriptions of marijuana derived
compounds are commonplace in several states with more pharmaceutical
treatments to follow. Hemp-derived CBD products and treatments abound. As of 2020, the only FDA approved
drug for treating epilepsy is Epidiolex, which contains a purified form
of CBD. The combination of THC and CBD has shown enhanced immune
system in cancer patients, relaxed arteries in patients with heart disease and
reduced muscle spasms in patients with Multiple Sclerosis.
The U.S. Hemp Farming Act was signed into law in December, 2018. The law
differentiates hemp from cannabis based on its total psychoactive content or
Total THC (% THCA + % d9-THC). Hemp is considered < 0.3 wt. %. The purpose
for this study is to build a simple and rugged HPLC method for differentiating
cannabis and hemp.
- Content Type:
- Document Number:
- Product Type:
- High Performance Liquid Chromatography (HPLC & UHPLC)
- Cannabis, Hemp, Cannabis & Hemp Testing Solutions, Cannabis Analyzer for Potency
- File Name:
- File Size:
Question about this literature?